Similarly, the variant rs58542926 E167K in transmembrane 6 superfamily member 2 (TM6SF2) gene which is involved in VLDL secretion, has been associated with the pathogenesis of NAFLD and with liver disease severity [63]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.